Clinical Trials for AMAL Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: AMAL Therapeutics

Clinical Trials (2)

NCT05846516
A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma
PHASE1Recruiting
94 participants
Started: Mar 13, 2023 · Completed: May 31, 2029
1 condition2 sponsors20 locations
NCT04046445
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
PHASE1Active, not recruiting
96 participants
Started: Jul 22, 2019 · Completed: Aug 31, 2025
6 conditions2 sponsors12 locations